China Oncology ›› 2013, Vol. 23 ›› Issue (9): 697-702.doi: 10.3969/j.issn.1007-3969.2013.09.001

Previous Articles     Next Articles

The study of secretory clusterin on the biological behaviors of non-small cell lung cancer cells

MA Xiao1,LUO Xiao-ying2,LI Zong-hai2,LI He-cheng1   

  1. 1.Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China;
    2.Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
  • Online:2013-09-25 Published:2014-02-20
  • Contact: LI He-cheng E-mail: lihecheng2000@hotmail.com

Abstract:

Background and purpose: Primary study showed that clusterin was associated with tumorigenicity. The goal of the study is to investigate the role of secretory clusterin in non-small cell lung cancer cell A549/H460. Methods: The lung cancer cell A549/H460 was treated with purified secretory clusterin, the Boyden Chamber migration assay was used to detected the migration of the lung cancer cell; the CCK8 assay was used to detected the growth of the cells; microRNA expression spectrum in H460 treated with secretory clusterin was analyzed, after that, we used the real-time florescence quantification detected the expression of microRNA in H460, and the biological function of microRNA molecular mechanisms of secretory clusterin was analyzed. Results: Secretory clusterin promoted the migration in A549/H460 (P<0.000 1); Secretory clusterin inhibited the growth in H460/A549 (P<0.000 1); MicroRNA-302b-3p, microRNA-23a-5p and microRNA-101-5p was overexpressed in H460 when treated with secretory clusterin. Conclusion: Secretory clusterin could promote the migration and inhibit the growth of lung cancer cellIt could change the microRNA expression spectrum as well. Our studies revealed that secretory clusterin could be used as a tool for further study, and it is a potential target in the treatment of lung cancer.

Key words: Secretory clusterin, Non-small cell lung cancer, Cell migration, MicroRNA